Koonal's research interests include health state valuation methodology and the use of social value judgements in health care decision making. He has published over 30 journal articles and book chapters on these topics, and has led research and consulting projects for health care providers, research foundations, policy makers and global pharmaceutical companies.
Recent projects include:
- A programme of empirical studies exploring societal preferences regarding the value of life-extending, end-of-life treatments. This project was funded by NICE’s Decision Support Unit.
- A study to develop methods to elicit health state values from the general public in the United Arab Emirates. This project was conducted in collaboration with local academics and the pharmaceutical industry.
- A workshop for managers at a global pharmaceutical company examining how ‘unmet need’ is defined and applied as a criterion underpinning regulatory and HTA decision making.
- A review of evidence on the health-related quality of long-term cancer survivors, and an assessment of implications for future technology appraisals in oncology. This project was commissioned by a pharmaceutical company.
- Research intended to create an EQ-5D-5L value set for England. This study was funded by the NIHR Policy Research Programme of the English Department of Health.
Koonal has a BA in Economics and Philosophy from the University of Nottingham, and an MSc (with distinction) in Health Economics from the University of York, and a PhD in Health Economics from University of Sheffield. Prior to joining OHE in 2008, he was a Business Analyst at Capital One in Nottingham. Koonal is a member of the EuroQol Group, and currently serves as co-chair of the Group’s Scientific Plenary Meeting, an annual conference.